Sponsor Pipeline

Jonathan Brammer Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
2
Recruiting
2
Disease Areas
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-07-29 NCT05141682
Oral Azacitidine for the Treatment of Relapsed or Refractory T-cell Large Granular…		 date change Completion pushed: 2026-06-30 -> 2026-09-30
Active Trials by Phase
Phase 2
2
Phase 1/2
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT05592015 Ruxolitinib for the Treatment of T-Cell Large Granular Lymphocytic Leukemia T-Cell Large Granular Lymphocyte Leukemia Recruiting
NCT07356245 Ruxolitinib Maintenance Post-Hematopoietic Stem Cell Transplant T-Cell Lymphoma T-cell Lymphoma Recruiting
Phase 1/2
NCT05141682 Oral Azacitidine for the Treatment of Relapsed or Refractory T-cell Large Granular… T-Cell Large Granular Lymphocyte Leukemia Active, Not Recruiting
Disease Areas
Leukemia (3) Non-Hodgkin Lymphoma (1)
Get alerts when Jonathan Brammer's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free